Lofexidine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lofexidine and local guidelines before prescribing.

Alpha-2 agonist

Mechanism

Central alpha-2 agonist.

Uses

Opioid withdrawal symptoms.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypotension, bradycardia, dry mouth, QT prolongation.

Interactions

QT-prolonging drugs.

Contraindications and cautions

QT prolongation

Monitoring

ECG, BP

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Supportive

Special advice

ECG in cardiac risk; taper over days.

More from the textbook: uses, cautions and other points
Where it is discussed in the book